Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Trending T
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Clinical Development
Biologics
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Dengue fever
Biotech
J&J links antiviral to protection from dengue in challenge trial
The oral candidate induced antiviral activity against dengue in a challenge study, offering encouragement as J&J works toward data in a larger trial.
Nick Paul Taylor
Oct 20, 2023 9:30am
Atea dumps dengue drug as forecast R&D timelines, costs spiral
Mar 1, 2023 6:50am
Novartis, GSK commit $1.25B to tropical disease R&D
Jun 23, 2022 5:52am
Takeda's data ready first dengue travel shot for approval
Jun 9, 2022 4:30am
T-cell adaptive vaccines close in on data in dengue, COVID-19
Apr 18, 2022 8:30am
Ex-FDA interim head Giroir returns to biotech to make antivirals
Feb 11, 2022 10:00am